List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1423 studies with search of:   "Cyclophosphamide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer
Condition: Early-Stage Breast Cancer
Interventions: Drug: genomically-guided treatment: Doxorubicin/Cyclophosphamide (AC) or Docetaxel/Cyclophosphamide (TC);   Drug: non-genomically-guided treatment: Doxorubicin/Cyclophosphamide (AC) or Docetaxel/Cyclophosphamide (TC)
2 Recruiting Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens
Condition: Breast Cancer
Interventions: Other: Standard Dose Dense Doxorubucin and Cyclophosphomide;   Other: Standard Doxorubucin and Cyclophosphomide;   Other: Standard Docetaxel, Carboplatin, and Herceptin;   Other: Standard Docetaxel, Doxorubucin and Cyclophosphomide;   Other: Standard Docetaxel and Cyclophosphomide
3 Active, not recruiting CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-Derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-Expressing Tumors
Condition: NY-ESO-1-Expressing Tumors
Interventions: Biological: Vaccine only;   Biological: Vaccine + cyclophosphamide;   Biological: Vaccine only;   Biological: Vaccine + cyclophosphamide;   Biological: Vaccine only;   Biological: Vaccine + cyclophosphamide
4 Active, not recruiting Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Drug: Rituximab
5 Recruiting Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone;   Drug: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
6 Recruiting Busulfan and Fludarabine Followed by Post-Transplant Cyclophosphamide
Conditions: Hematologic Diseases;   Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Cyclophosphamide
7 Recruiting Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide, methotrexate, fluorouracil, PEG-filgrastim;   Drug: cyclophosphamide, methotrexate, fluorouracil, PEG-filgrastim
8 Active, not recruiting Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab
Condition: Lymphoma
Interventions: Drug: 2CdA;   Drug: Cyclophosphamide;   Drug: Rituximab
9 Active, not recruiting A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
Conditions: Breast Cancer;   Ovarian Cancer;   Prostate Cancer;   Colon Cancer;   Renal Cancer
Intervention: Drug: Cyclophosphamide & ZYC300 (ZYC300 with cyclophosphamide pre-dosing)
10 Active, not recruiting Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
Conditions: High Risk;   Breast Cancer;   Positive Nodes;   Cyclophosphamide;   Doxorubicin
Interventions: Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: G-CSF;   Drug: tamoxifen;   Drug: ciprofloxacin
11 Recruiting Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: sorafenib and cyclophosphamide
12 Recruiting Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis
Condition: Amyloidosis
Interventions: Drug: cyclophosphamide;   Drug: lenalidomide;   Drug: dexamethasone
13 Recruiting Double Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Neuroblastoma;   Immunodeficiencies;   Anemia
Interventions: Drug: TBI, Thiotepa, Cyclophosphamide, ATG;   Drug: Busulfan, Melphalan, Rabbit ATG;   Drug: Busulfan, Fludarabine, Alemtuzumab;   Drug: Busulfan, Fludarabine, Rabbit ATG;   Drug: Fludarabine, Cyclophosphamide, ATG;   Drug: Busulfan, Cyclosphosphamide, Rabbit ATG,
14 Active, not recruiting Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
Conditions: Breast Neoplasms;   Adjuvant;   Chemotherapy
Interventions: Drug: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide;   Drug: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide
15 Recruiting Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: Abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
16 Recruiting A Pharmacokinetic and Phase II Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Cyclophosphamide and Topotecan
17 Active, not recruiting Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
Conditions: Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Polyarteritis Nodosa
Interventions: Drug: prednisone, methylprednisolone,cyclophosphamides;   Drug: Cyclophosphamide, Azathioprine,prednisone,methylprednisolone;   Drug: Mycophenolate mofetil,methotrexate
18 Active, not recruiting CFAR Study in Patients With Chronic Lymphocytic Leukemia
Conditions: Leukemia;   Chronic Lymphocytic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Alemtuzumab;   Drug: Rituximab
19 Recruiting Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With MM
Condition: Multiple Myeloma
Interventions: Drug: Cyclophosphamide;   Drug: Bortezomib; Pegylated Liposomal Doxorubicin; Dexamethasone
20 Recruiting Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Prednisone

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services